Find Ginsenoside Rb1 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Gynosaponin c, 41753-43-9, Gypenoside iii, Sanchinoside e1, Arasaponin e1, Panax saponin e
Molecular Formula
C54H92O23
Molecular Weight
1109.3  g/mol
InChI Key
GZYPWOGIYAIIPV-JBDTYSNRSA-N
FDA UNII
7413S0WMH6

Ginsenoside Rb1
(2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-7-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-11-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol is a natural product found in Panax vietnamensis, Gynostemma pentaphyllum, and other organisms with data available.
1 2D Structure

Ginsenoside Rb1

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2.1.2 InChI
InChI=1S/C54H92O23/c1-23(2)10-9-14-54(8,77-48-44(69)40(65)37(62)29(74-48)22-70-46-42(67)38(63)34(59)26(19-55)71-46)24-11-16-53(7)33(24)25(58)18-31-51(5)15-13-32(50(3,4)30(51)12-17-52(31,53)6)75-49-45(41(66)36(61)28(21-57)73-49)76-47-43(68)39(64)35(60)27(20-56)72-47/h10,24-49,55-69H,9,11-22H2,1-8H3/t24-,25+,26+,27+,28+,29+,30-,31+,32-,33-,34+,35+,36+,37+,38-,39-,40-,41-,42+,43+,44+,45+,46+,47-,48-,49-,51-,52+,53+,54-/m0/s1
2.1.3 InChI Key
GZYPWOGIYAIIPV-JBDTYSNRSA-N
2.1.4 Canonical SMILES
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C
2.1.5 Isomeric SMILES
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C
2.2 Other Identifiers
2.2.1 UNII
7413S0WMH6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-glcglc-20-glcglc-ginsenoside

2. Arasaponin E1

3. Ginsenoside-rb1

4. Gynosaponin C

5. Gypenoside Iii

6. Notoginsenoside Rb1

7. Panax Saponin E

8. Panaxoside Rb1

9. Pseudoginsenoside D

10. Sanchinoside E1

11. Sanchinoside Rb1

2.3.2 Depositor-Supplied Synonyms

1. Gynosaponin C

2. 41753-43-9

3. Gypenoside Iii

4. Sanchinoside E1

5. Arasaponin E1

6. Panax Saponin E

7. Pseudoginsenoside D

8. Ginsenoside-rb1

9. Panaxsaponin E

10. (20s)-ginsenoside Rb1

11. Chembl501515

12. Grb 1

13. Chebi:67989

14. Sanchinoside Rb1

15. 7413s0wmh6

16. Notoginsenoside Rb1

17. 2-o-beta-glucopyranosyl-(3beta,12beta)-20-[(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl Beta-d-glucopyranoside

18. Ginsenosiderb1

19. Einecs 255-532-8

20. Mfcd00133367

21. Panaxoside Rb1

22. 2-o-beta-glucopyranosyl-(3beta,12beta)-20-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-d-glucopyranoside

23. Unii-7413s0wmh6

24. Gypenoside Cento

25. Nsc-310103

26. Nsc 310103

27. Gsrb1

28. Gs-rb1

29. 20(s)-ginsenoside Rb1

30. Ginsenoside Rb1 - 94%

31. Bidd:er0108

32. Ginsenoside Rb1 [usp-rs]

33. Ginsenoside Rb1 [who-dd]

34. Dtxsid401316929

35. Hms3885o12

36. Ex-a6786

37. Hy-n0039

38. Bdbm50317541

39. S3924

40. Akos025311537

41. Ccg-270640

42. Cs-3829

43. Db06749

44. Ncgc00347398-04

45. Bs-32417

46. Xg164977

47. N1620

48. C20713

49. 753g439

50. Q-100470

51. Ginsenoside Rb1, Primary Pharmaceutical Reference Standard

52. Ginsenoside Rb1, European Pharmacopoeia (ep) Reference Standard

53. Ginsenoside-rb1 From Panax Ginseng (korean Ginseng) Root, Triterpenoid Saponin

54. (3beta,12beta)-20-[(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside

55. (3beta,12beta)-20-{[6-o-(beta-d-glucopyranosyl)-beta-d-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside

56. .beta.-d-glucopyranoside, (3.beta.,12.beta.)-20-((6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-.beta.-d-glucopyranosyl-

57. 3beta-[beta-d-glucopyranosyl-(1->2)-beta-d Glucopyranosyloxy]-20-[beta-d-glucopyranosyl-(1->2)-beta-d Glucopyranosyloxy]dammar-24-en-12beta-ol

58. Beta-d-glucopyranoside, (3-beta,12-beta)-20-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-

59. Ginsenoside Rb1 (constituent Of American Ginseng, Asian Ginseng, And Tienchi Ginseng) [dsc]

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 1109.3 g/mol
Molecular Formula C54H92O23
XLogP30.3
Hydrogen Bond Donor Count15
Hydrogen Bond Acceptor Count23
Rotatable Bond Count16
Exact Mass1108.60293918 g/mol
Monoisotopic Mass1108.60293918 g/mol
Topological Polar Surface Area377 Ų
Heavy Atom Count77
Formal Charge0
Complexity2000
Isotope Atom Count0
Defined Atom Stereocenter Count30
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty